Applied Therapeutics, Inc. (APLT) Covered Calls

You can sell covered calls on Applied Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for APLT (prices last updated Mon 12:30 PM ET):

Applied Therapeutics, Inc. (APLT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
8.91 +0.22 8.91 8.93 479K - 1.0
Covered Calls For Applied Therapeutics, Inc. (APLT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 10 1.50 7.43 20.2% 223%
Jan 17 10 1.70 7.23 23.5% 141%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that is in phase I/II for the treatment of galactosemia; AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy; and AT-003 that is in phase I clinical trial for the treatment diabetic retinopathy. The company's preclinical stage products include AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.